Entezari Heravi Nazanin, Hosseinian Sara, Naji Ebrahimi Yazd Zohreh, Shafei Mohammad Naser, Ebrahimzadeh Bideskan Alireza, Shahraki Samira, Samadi Noshahr Zahra, Motejadded Fatemeh, Beheshti Farimah, Mohebbati Reza, Parhizgar Soghra, Khajavi Rad Abolfazl
Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Avicenna J Phytomed. 2018 Mar-Apr;8(2):179-187.
The aim of the present study was to evaluate the possible protective effect of () extract against doxorubicin (DXR)-induced renal inflammation in rats.
80 male albino rats were randomly divided into 8 groups as follows: control, DXR, Ext (extract) 600, Ext1200, dexamethasone+DXR, vitamin E+DXR, Ext600+DXR and Ext1200+DXR. Duration of the study was 35 days and DXR was intravenously injected on the 7 day of the experiment. Tumor necrosis factor-alpha (TNF-α) production and monocyte chemoattractant protein-1 (MCP-1) expression levels were assessed in the left kidney. Serum creatinine concentration and osmolarity were determined on the 1, 14, 21, 28 and 35 days of the experiment.
DXR caused a significant increase in renal expression of MCP-1 and TNF-α production compared to control animals. Administration of dexamethasone, vitamin E and extract significantly improved the expression of these inflammatory mediators compared to DXR group. Compared to day 1 in DXR group, serum osmolarity showed a significant increase on days 21, 28 and 35. Also, on these days, serum osmolarity in DXR group was significantly higher than that on the same days in control group. In Vit E+DXR and Ext 1200+DXR groups, there was no significant changes in serum osmolarity among different days of the study. However, in these groups, serum osmolarity on days 21, 28 and 35 showed a significant decrease compared to the same days in DXR group.
Present results suggest that hydroethanolic extract of protected renal tissue against DXR-induced renal inflammation.
本研究旨在评估()提取物对阿霉素(DXR)诱导的大鼠肾脏炎症的可能保护作用。
80只雄性白化大鼠随机分为8组,如下:对照组、DXR组、提取物600组、提取物1200组、地塞米松+DXR组、维生素E+DXR组、提取物600+DXR组和提取物1200+DXR组。研究持续35天,在实验第7天静脉注射DXR。评估左肾中肿瘤坏死因子-α(TNF-α)的产生和单核细胞趋化蛋白-1(MCP-1)的表达水平。在实验的第1、14、21、28和35天测定血清肌酐浓度和渗透压。
与对照动物相比,DXR导致肾脏中MCP-1的表达和TNF-α的产生显著增加。与DXR组相比,给予地塞米松、维生素E和提取物显著改善了这些炎症介质的表达。与DXR组第1天相比,血清渗透压在第21、28和35天显著升高。此外,在这些天,DXR组的血清渗透压显著高于对照组同一天的水平。在维生素E+DXR组和提取物1200+DXR组中,研究不同天数之间血清渗透压无显著变化。然而,在这些组中,第21、28和35天的血清渗透压与DXR组同一天相比显著降低。
目前的结果表明,()的水乙醇提取物可保护肾脏组织免受DXR诱导的肾脏炎症。